Your contributions are just about trading. You would have people believe this is same old same old and not a revolution in medicine. If @ecoool2 calls it the biggest opportunity he has seen on the ASX and certainly comparable to CSL, then I'm inclined to believe him over you. Because he provides substance.
MSB is not wholly focussed on the FDA. But this is just a bump in the road.
Traders love to amplify the drama. They have no concept that biotechs take at least 10 years to mature and MSB is certainly no one trick pony. CSL took a long time and it was under development before listing.
People understand you will go to any lengths to provide a distraction.
Unlike you I'm not playing to the crowd. Certainly not traders. There is no depth to your analysis. Just lazy attacks.
MSB to dispute FDA finding in Type A meeting, page-530
-
- There are more pages in this discussion • 488 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.165M | 1.849M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 40188 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 28520 | 16 |
View Market Depth
| Last trade - 12.55pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |